University of Melbourne
Also known as: 3. Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville Victoria Australia | Austin and Repatriation Hospital | Austin Health, University of Melbourne | Austin Hospital and University of Melbourne | Austin Hospital, Melbourne Australia | Austin Hospital & University of Melbourne | Austin Hospital, University of Melbourne | Austin Hospital, VIC, Australia | Austin & Northern Hospitals, University of Melbourne | Australian National University, Canberra, Australia | Centre for Youth Mental Health, University of Melbourne, Australia | Department of Anaesthesia, Royal Victoria Hospital, MUHC | Department of Neurology, Royal Melbourne Hospital | Director Department of Nephrology, The Royal Melbourne Hospital | Director of Anaesthesia, Royal Melbourne Hospital | Director of Clinical Haematology, Austin Hospital, Australia | Intensive Care Unit Research Department, Royal Melbourne Hospital | Intensive Care Unit, Royal Melbourne Hospital | Melbourne Children's Campus (incorporating The Royal Children's Hospital, Murdoch Children's Research Institute, the University of Melbourne Department of Paediatrics) | Melbourne Health and University of Melbourne | Melbourne Health Dept of Neurology & The University of Melbourne Dept of Medicine | Melbourne Heart Centre, Royal Melbourne Hospital | Melbourne Sexual Health Centre | Menzies School of Health Research and University of Melbourne | Murdoch Children Research Institute/Royal Children Hospital, Melbourne | Murdoch Children's Research Institute, Royal Children's Hospital, University of Melbourne | Murdoch Children's Research Institute, Vicotria, Australia | ORYGEN Research Centre , ORYGEN Youth Health,Department of Psychiatry, University of Melbourne | ORYGEN Research Centre, University of Melbourne | ORYGEN Youth Health, University of Melbourne, Department of Psychiatry | Peter Doherty Institute for Infection and Immunity, The University of Melbourne | Royal Children's Hospital | Royal Children's Hospital, Brisbane, Herston, QLD, Australia | Royal Children's Hospital, Brisbane, QLD, Australia | Royal Children's Hospital, Melbourne | Royal Children's Hospital Melbourne Australia | Royal Children's Hospital Melbourne (Australia) | Royal Children's Hospital, Parkville, Victoria, Australia | Royal Children's Hospital, Queensland Paediatric Infectious Diseases Laboratory | Royal Melbourne Hospital | Royal Melbourne Hospital, Head, Diabetic Foot Unit | Royal Melbourne Hospital, Intensive Care Unit | Royal Victoria Eye and Ear Hospital | Royal Victoria Eye & Ear Hospital, Department of Ophthalmology, University of Melbourne | Royal Victoria Hospital | Royal Victoria Hospital, Canada | Royal Victoria Hospital - Montreal | Royal Victoria Hospital, Montreal, Canada | Royal Victoria Hospital Of Barrie | Royal Victoria Infirmary | Royal Women's Hospital | Royal Womens Hospital Melbourne | Sir James Spence Institute of Child Health at Royal Victoria Infirmary | Stuart Mazzone | The Doherty Institute, University of Melbourne | The Peter Doherty Institute for Infection and Immunity (Doherty Institute), University of Melbourne | The Peter Doherty Institute for Infection and Immunity, University of Melbourne | The Royal Children's Hospital Melbourne | The Royal Victoria Hospital | The Royal Victoria Hospital of Barrie | The Royal Women Hospital | The Royal Women's Hospital | The Royal Womens Hospital Melbourne | The Univeristy of Melbourne and Murdoch Childrens Research Institute | The University of Melbourne and Murdoch Childrens Research Institute | The University of Melbourne and The Melbourne Clinic | University of Melbourne | University of Melbourne, Australia | University of Melbourne, Department of Psychiatry, ORYGEN Research Centre | Victorian Comprehensive Cancer Centre
Highest phase reached
Phase 4
First clinical trial
May 1, 1995Last known activity
Feb 28, 2026
Timeline
1850s
- Jan 1, 1853
University of Melbourne— Founded
Drugs by trial phase (207 distinct, 156 trials)
Phase 4 (44 own, 0 via acquisition)
Phase 3 (80 own, 0 via acquisition)
Phase 2 (48 own, 0 via acquisition)
Phase 1 (15 own, 0 via acquisition)
Indications
Studied for
- Abortion, Missed
- Abortion, Spontaneous
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Anemia
- Anxiety Disorders
- Apnea
- Ataxia
- Bacteremia
- Bacterial Infections
- Bipolar Disorder
- Breast Neoplasms
- Bronchiolitis
- Bronchiolitis, Viral
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Central Nervous System Neoplasms
- Cerebellar Ataxia
- Cerebral Hemorrhage
- Cerebral Palsy
- Choroidal Neovascularization
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Communicable Diseases
- Congenital Abnormalities
- Conjunctivitis
- Conjunctivitis, Allergic
- Constipation
- Coronavirus Infections
- Critical Illness
- Cystic Fibrosis
- Delirium
- Depression
- Depression, Postpartum
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disease
- Ear Diseases
- Eczema
- Edema
- Emergencies
- Enteropathy-Associated T-Cell Lymphoma
- Fetal Nutrition Disorders
- Fibrosis
- Food Hypersensitivity
- Friedreich Ataxia
- Glaucoma
- Glaucoma, Open-Angle
- Glioma
- Glomerulonephritis
- Gonorrhea
- Gram-Positive Bacterial Infections
- Graves Disease
- Heart Defects, Congenital
- Hemolysis
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- HIV Infections
- Hodgkin Disease
- Hypersensitivity
- Hypertriglyceridemia
- Hypoplastic Left Heart Syndrome
- Infections
- Inflammatory Bowel Diseases
- Influenza, Human
- Intestinal Diseases
- Intestinal Neoplasms
- Kidney Diseases
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Macular Edema
- Malaria
- Malaria, Vivax
- Mental Disorders
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Multiple Myeloma
- Muscular Dystrophy, Facioscapulohumeral
- Mycobacterium Infections
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Neovascularization, Pathologic
- Nervous System Neoplasms
- Neurodevelopmental Disorders
- Neurotoxicity Syndromes
Recent trials (50)
- NCT07225465CollaboratorPhase 2Feb 28, 2026
- NCT07253688CollaboratorPhase 3Nov 30, 2025
- NCT06972849Lead sponsorN/AOct 31, 2025
- NCT06972849OfficialN/AOct 31, 2025
- NCT06906757Lead sponsorN/ASep 30, 2025
- NCT07145736CollaboratorPhase 4Aug 4, 2025
- NCT06960759CollaboratorPhase 2Aug 1, 2025
- NCT06992141CollaboratorEarly Phase 1Jul 24, 2025
- NCT06965751Lead sponsorPhase 1Jun 27, 2025
- NCT06965751OfficialPhase 1Jun 27, 2025
- NCT06993103CollaboratorPhase 4Jun 2, 2025
- NCT06993103CollaboratorPhase 4Jun 2, 2025
- NCT06898853CollaboratorN/AMay 1, 2025
- NCT06461429Lead sponsorN/AFeb 1, 2025
- NCT06650501CollaboratorPhase 4Jan 7, 2025
Details
- Founded
- Melbourne, AU Jan 1, 1853
- Last known activity
- Feb 28, 2026